Skip to main content

The Green Organic Dutchman Holdings Ltd (TGOD-T) Quote

Unchecking box will stop auto data updates
TSX Real-Time Last Sale CAD
Today's Change
Price Quote as of

Today's Trading

Day Low 0.97
Day High 1.04
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

The Green Organic Dutchman Holdings Ltd through its subsidiary operates as a cannabinoid-based research and development company in Canada. The company has two operating segments namely production and distribution of cannabis and related products and Hemp related products. It produces organic cannabis products, including organic dried cannabis, cannabis oils and edibles, fresh cannabis, and seeds for medical applications. Geographically, it generates maximum revenue from Europe.


Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio


Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Craft Cultivators Amass Plaudits as the Cannabis Industry Swells
- PR Newswire - Thu Nov 7, 8:00AM CST
PR Newswire - CMTX
Thu Nov 7, 8:00AM CST
Canada became just the second nation ever to legalize cannabis in 2018. However, despite legalization, the industry continues to face multiple legal barriers within its borders. But, despite hindrances, the Canadian market is projected to experience one of the fastest growth rates among global markets. Additionally, Canada's legal spending on the plant is also expected to grow at a much more rapid rate compared to other regions, primarily because of its large addressable market. In comparison, Uruguay's cannabis market is still relatively small, despite having legalized cannabis entirely nearly 6 years ago. In 2018, it was estimated that 147,000 Uruguayans between the ages of 18 and 65 consumed cannabis, according to CBS. On the other hand, Statistics Canada estimated that approximately 5.3 million or 18% of Canadians aged 15 years and older reported using cannabis during the first quarter of legalization. Nonetheless, a major drawback to a large consumer base is that it makes it challenging for cultivators and vendors to meet the demand, especially when the industry is relatively new. Consequently, Canadian retailers experienced nationwide shortages due to limited licensing approvals. And, as such, many Canadian provinces decided to provide additional licenses to operators in order to close the growing gap between the supply and demand. And while Canada has officially marked its first year of legal cannabis sales just last month, the marketplace is still in its infancy stage. Now, as regulations begin to loosen, the Canadian legal industry is positioned for exponential growth. And according to data compiled by ArcView Market Research and BDS Analytics, the worldwide consumer spending on legal cannabis reached an estimated USD 12.2 Billion in 2018. By 2022, it is expected for consumer spending to reach USD 31.3 Billion while registering a CAGR of 26.7% from 2017 to 2022. Pasha Brands Ltd. (OTC: CRFTF) (CSE: CRFT), Canopy Growth Corporation (NYSE: CGC) (TSX: WEED), Aphria Inc. (NYSE: APHA) (TSX: APHA), Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), The Green Organic Dutchman Holdings Ltd. (OTC: TGODF) (TSX: TGOD)
The Green Organic Dutchman Holdings to Release Third Quarter 2019 Earnings Results After Market Close on November 14, 2019
- PR Newswire - Tue Nov 5, 3:30PM CST
PR Newswire - PRNW
Tue Nov 5, 3:30PM CST
TORONTO , Nov. 5, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. ("TGOD" or the "Company") (TSX: TGOD) (US: TGODF), a leading producer of premium certified organic cannabis, announced today that the Company expects to release its third quarter 2019 earnings on Thursday, November 14, 2019 after market close. The Company will hold a conference call conducted by Brian Athaide , Chief Executive Officer, and Sean Bovingdon , Chief Financial Officer, on November 15, 2019 at 9:00 am Eastern Time to discuss the results and future outlook.
Giant Breakthroughs With Psychedelics is Creating Incredible Investment Opportunities
- PR Newswire - Tue Nov 5, 7:50AM CST
PR Newswire - CMTX
Tue Nov 5, 7:50AM CST
Research into psychedelics for the treatment of anxiety, depression, and other mental illnesses has only begun to expand - and investors are excited. Studies have already shown that when it's "ingested it transforms into a psychoactive chemical in the body that might help dramatically reduce symptoms of depression, messing with the brain's pre-frontal cortex, which affects our mood and perception of things and another part of your brain, that's a part of processing emotional reaction to fear and anxiety," as reported by Spectrum News. Plus, in recent months, Johns Hopkins Medicine announced the launch of the Center for Psychedelic and Consciousness Research to study compounds like LSD and psilocybin to treat a range of mental health problems, including anorexia, addiction and depression. Psychiatrists at Johns Hopkins University even found that mushrooms can help with smoking cessation, and another study found it can assist with alcohol dependence, for example. Researchers at New York University found psilocybin mushrooms caused a "rapid and sustained" reduction in anxiety and depression in patients with cancer, as reported by the Financial Post. Better, over the last year, Denver, Colorado, and Oakland, California decriminalized the possession of products containing psilocybin or psilocin. As excitement builds, it's opening a range of opportunity for companies that have already established launching cannabis products including The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF), The Green Organic Dutchman (TSX:TGOD) (OTCQX:TGODF), Canopy Growth Corporation (TSX:WEED) (NYSE:CGC), The Supreme Cannabis Company Inc. (TSX:FIRE) (OTCQX:SPRWF), and Flowr Corporation (TSX-V:FLWR) (OTCPK:FLWPF).
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 0.91 +13.19% increase
on 10/31/19
Period Open:1.19
Price movement based on the high, low and last over the given period.
1.44 -28.47% decrease
on 10/17/19
-0.16 (-13.45%) decrease
since 10/11/19
3-Month 0.91 +13.19% increase
on 10/31/19
Period Open:3.44
Price movement based on the high, low and last over the given period.
3.69 -72.09% decrease
on 08/13/19
-2.41 (-70.06%) decrease
since 08/09/19
52-Week 0.91 +13.19% increase
on 10/31/19
Period Open:4.11
Price movement based on the high, low and last over the given period.
5.81 -82.27% decrease
on 03/19/19
-3.08 (-74.94%) decrease
since 11/09/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).